Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer

High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

(2020) Nerea Muñoz-Unceta et al.   EUROPEAN JOURNAL OF CANCER

TEMPORARY REMOVAL: ROS1-rearranged non-small cell lung cancer is associated with high rate of venous thromboembolism: analysis from a phase II, prospective, multicentre, two-arms trial (METROS)

(2019) Rita Chiari et al.   Clinical Lung Cancer

Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study

(2019) Feifei Dou et al.   THROMBOSIS RESEARCH

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

(2018) Andrés J. Muñoz Martín et al.   BRITISH JOURNAL OF CANCER

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

(2018) Ingrid Pabinger et al.   Lancet Haematology

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events

(2018) Terry L. Ng et al.   Journal of Thoracic Oncology

Cancer and Venous Thromboembolic Disease: A Review

(2017) Eoin Donnellan et al.   ONCOLOGIST

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

(2016) Alex J Walker et al.   BRITISH JOURNAL OF CANCER

Epidemiology and risk factors for venous thromboembolism in lung cancer

(2016) Cihan Ay et al.   CURRENT OPINION IN ONCOLOGY

Prevalence and Associations of VTE in Patients With Newly Diagnosed Lung Cancer

(2014) Yuhui Zhang et al.   CHEST

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

(2012) Melina Verso et al.   Internal and Emergency Medicine

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

(2011) David H. Henry et al.   AMERICAN JOURNAL OF HEMATOLOGY

Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis

(2011) Benqiang Rao et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Neutrophil extracellular traps promote deep vein thrombosis in mice

(2011) A. BRILL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia

(2011) John A Livesey et al.   THORAX

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD

Venous thromboembolism and nonsmall cell lung cancer

(2009) Lisa K. Hicks et al.   CANCER

Increased Tissue Factor Expression Is Associated with Reduced Survival in Non-Small Cell Lung Cancer and with Mutations of TP53 and PTEN

(2009) S. Regina et al.   CLINICAL CHEMISTRY

Genetic Link Between Cancer and Thrombosis

(2009) Carla Boccaccio et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD